Profil bibliographique

Jason Boer

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

46Publications signalées

1590Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

PI3K/AKT/mTOR signaling in cancerCancer Mechanisms and TherapySynthesis and biological activityCytokine Signaling Pathways and InteractionsPharmacogenetics and Drug Metabolism

Publications récentes

2026 articleOpenAlex

Discovery of the Orally Bioavailable Isoform Selective Janus Kinase 1 (JAK1) Compound Povorcitinib (INCB054707) for the Treatment of Inflammatory and Autoimmune Diseases

卓金聪, Yunlong Li, Ding‐Quan Qian, David Burns et autres

1 citationJournal of Medicinal Chemistry

Accès ouvert 2026 articleOpenAlex

Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends

Jason Boer, Ellen A. Cannady, Filip Cuyckens, Ulrike Glaenzel et autres

0 citationsClinical Pharmacology & Therapeutics

Accès ouvert 2025 articleOpenAlex

Guided Sample Pooling in Human Mass Balance Studies: A Recommended Strategic Decision Framework

Filip Cuyckens, W.‐S. Li, Adam Auclair, Kenneth C. Cassidy et autres

1 citationClinical Pharmacology & Therapeutics

Accès ouvert 2025 articleOpenAlex

2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in Bioanalysis; Tear Sample Collection; Radiolabeled Mass Balance Studies; Chiral Assays; Bioanalysis of Antibody-Oligonucleotide & Bicycle Drug Conjugates ( PART 1A – Recommendations on Mass Spectrometry Assays, Chromatography, Sample Preparation and Regulated Bioanalysis Sampling, Validating, Analyzing & Reporting PART 1B – Regulatory Agencies’ Input on Regulated Bioanalysis/BMV)

John Wojcik, Mark G. Qian, Anton I. Rosenbaum, Estelle M. Maes et autres

5 citationsBioanalysis

Accès ouvert 2024 articleOpenAlex

2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis PART 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)

Mike Baratta, Wenying Jian, Shawna Hengel, Surinder Kaur et autres

12 citationsBioanalysis

2024 conference-abstractOpenAlex

Abstract 5900: INCB161734: A novel, potent, and orally bioavailable KRAS G12D selective inhibitor demonstrates antitumor activity in KRAS G12D mutant tumors

Matthew R. Farren, Valerie Roman, Alexandra Gallion, Abdellah Allali‐Hassani et autres

16 citationsCancer Research

Accès ouvert 2023 articleOpenAlex

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group

Wenkui Li, Faye Vazvaei‐Smith, Gordon J. Dear, Jason Boer et autres

14 citationsClinical Pharmacology & Therapeutics

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table 1 from A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figures 1-3 from A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figures Legends 1-3, Table Legend from A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.